Atlas Trials

huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

Clinical trial NCT03103971 · TERMINATED

Trial details

NCT number
NCT03103971
Sponsor
Fred Hutchinson Cancer Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Adult Acute Lymphoblastic LeukemiaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Primary Mediastinal (Thymic) Large B-Cell LymphomaRefractory Adult Acute Lymphoblastic LeukemiaRefractory B-Cell Non-Hodgkin LymphomaRefractory Diffuse Large B-Cell LymphomaRefractory Primary Mediastinal (Thymic) Large B-Cell LymphomaRecurrent Transformed Non-Hodgkin LymphomaRecurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 RearrangementsRefractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 RearrangementsRecurrent B Acute Lymphoblastic Leukemia
Start date
2017-11-03
Primary completion
2023-03-23
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.